iShares大型股10%目標緩衝12月主動型ETF TEND 深 滬
等待開盤 06-25 09:30:00 美东时间
26.9001
-0.050
-0.19%
華盛通- 最 高27.049
- 今 開27.00
- 成交量 2.42万股
- 最 低 26.87
- 昨 收 26.95
- 總市值 6348.42万
- 52周最高 27.31
- 市盈率 靜 --
- 換手率 1.02%
- 52周最低 24.24
- 委 比 0.00%
- 總股本 236.00万
- 歷史最高 27.31
- 量 比 2.36
- 振 幅 0.66%
- 歷史最低 24.24
- 每 手 1
- 風險率 0.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Pierre Et Vacances Receives Binding Offer from Mubadala Capital
BRIEF-Pierre Et Vacances Receives Binding Offer from Mubadala Capital June 22 (Reuters) - Pierre et Vacances SA PVAC.PA : RECEIVES FULLY FINANCED BINDING OFFER FROM MUBADALA CAPITAL BOARD OF DIRECTORS WELCOMES MUBADALA CAPITAL OFFER OFFER TERMS: €1.9 PER SHARE 'CUM DISTRIBUTION', UP TO €2 PER SHARE
06-22 16:09
BRIEF-Ford Is Recalling 10,742 U.S. Vehicles - NHTSA
BRIEF-Ford Is Recalling 10,742 U.S. Vehicles - NHTSA June 16 (Reuters) - FORD MOTOR COMPANY IS RECALLING 10,742 U.S. VEHICLES - NHTSA FORD MOTOR COMPANY IS RECALLING SOME U.S. VEHICLES AS UNINTENDED GEAR SELECTION MAY CAUSE THE VEHICLE TO MOVE IN AN UNEXPECTED DIRECTION, INCREASING THE RISK OF CRASH
06-16 15:12
BRIEF-Arch Capital Announces Early Results Of Cash Tender Offers Up To $417.9 Million
BRIEF-Arch Capital Announces Early Results Of Cash Tender Offers Up To $417.9 Million June 15 (Reuters) - Arch Capital Group Ltd ACGL.O : ARCH CAPITAL GROUP LTD. ANNOUNCES EARLY RESULTS OF CASH TENDER OFFERS TO PURCHASE UP TO AN INCREASED CAPPED AMOUNT OF CERTAIN OF ITS SUBSIDIARIES’ DEBT SECURITIES
06-16 08:22
BRIEF-J.S.B.: Warburg Pincus To Launch Tender Offer For J.S.B. Shares
BRIEF-J.S.B.: Warburg Pincus To Launch Tender Offer For J.S.B. Shares June 12 (Reuters) - J.S.B. Co Ltd 3480.T : J.S.B.: WARBURG PINCUS TO LAUNCH TENDER OFFER FOR J.S.B. SHARES J.S.B.: WARBURG PINCUS TO OFFER 9,000 YEN FOR EACH J.S.B. SHARE J.S.B.: WARBURG PINCUS' TENDER OFFER TO RUN FROM JUNE 15 TO
06-12 18:33
BRIEF-Hyperscale Data, Inc. Announces Preliminary Results For Tender Offer
BRIEF-Hyperscale Data, Inc. Announces Preliminary Results For Tender Offer June 9 (Reuters) - Hyperscale Data Inc GPUS.A : HYPERSCALE DATA, INC. ANNOUNCES PRELIMINARY RESULTS FOR TENDER OFFER HYPERSCALE DATA - ABOUT 8.54 MILLION SHARES VALIDLY TENDERED; 309,828 SHARES VIA GUARANTEED DELIVERY HYPERSC
06-09 18:04
BRIEF-AIFA Issues Formal Clarification & Refutation On Share Acquisition Transaction Involving HyalRoute
BRIEF-AIFA Issues Formal Clarification & Refutation On Share Acquisition Transaction Involving HyalRoute June 8 (Reuters) - All in Futuretech Alliance Inc AIFA.O : AIFA ISSUES FORMAL CLARIFICATION AND REFUTATION REGARDING THE SHARE ACQUISITION TRANSACTION INVOLVING HYALROUTE COMMUNICATION GROUP LIMI
06-08 22:37
BRIEF-OpenAI Plots Biggest ChatGPT Overhaul Since Launch - FT
BRIEF-OpenAI Plots Biggest ChatGPT Overhaul Since Launch - FT June 7 (Reuters) - OPENAI PLOTS BIGGEST CHATGPT OVERHAUL SINCE LAUNCH - FT OPENAI INTENDS TO TRANSFORM CHATGPT INTO A "SUPERAPP" THAT COMBINES CODING TOOLS AND AI AGENTS - FT Source text: https://tinyurl.com/pd3ut3mp Further company cover
06-07 12:04
BRIEF-Bodycote Says Apollo Does Not Intend To Make Firm Offer For Bodycote
BRIEF-Bodycote Says Apollo Does Not Intend To Make Firm Offer For Bodycote June 5 (Reuters) - Bodycote PLC BOY.L : BODYCOTE - APOLLO DOES NOT INTEND TO MAKE FIRM OFFER FOR BODYCOTE BODYCOTE - NO LONGER IN OFFER PERIOD FOLLOWING APOLLO ANNOUNCEMENT Source text: ID:nPRr52392a Further company coverage:
06-05 14:24
BRIEF-Parabilis Medicines - Estimated IPO Price Per Share Between $17 And $19 - SEC Filing
BRIEF-Parabilis Medicines - Estimated IPO Price Per Share Between $17 And $19 - SEC Filing June 4 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O : PARABILIS MEDICINES - ESTIMATED IPO PRICE PER SHARE BETWEEN $17 AND $19 - SEC FILING PARABILIS MEDICINES - ANNOUNCES IPO OF 25 MILLION SHARES - SEC FIL
06-04 18:32
BRIEF-Xbrane Gets FDA BsUFA Review Date
BRIEF-Xbrane Gets FDA BsUFA Review Date June 4 (Reuters) - Xbrane Biopharma AB XBRANE.ST : SAID ON WEDNESDAY, U.S. FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTED RESUBMITTED BIOLOGICS LICENSE APPLICATION FOR CO'S INVESTIGATIONAL BIOSIMILAR CANDIDATE TO LUCENTIS (RANIBIZUMAB) FDA SET A BSUFA (BIOSIMILAR
06-04 14:23
